EMANUEL B. SCHOENBACH, M.D., F.A.C.P.; JOSEPH M. MILLER, M.D.; PERRIN H. LONG, M.D.
This content is PDF only. Please click on the PDF icon to access.
Although infrequent in occurrence, blastomycotic infections are important because of the morbidity and mortality associated with the systemic form of the disease. Treatment has been varied and generally ineffectual. The observation of Elson7 that certain of the diamidines exerted a fungistatic effect on Blastomyces dermatitidis led to the treatment of a patient suffering from systemic blastomycosis with two of the diamidines.
Blastomycosis is seen in both the white and Negro races, usually in the third through the fifth decades of life and in the lower economic strata. The incidence is much higher in males. Farmers are more frequently affected than
SCHOENBACH EB, MILLER JM, LONG PH. THE TREATMENT OF SYSTEMIC BLASTOMYCOSIS WITH STILBAMIDINE1. Ann Intern Med. 1952;37:31–47. doi: 10.7326/0003-4819-37-1-31
Download citation file:
Published: Ann Intern Med. 1952;37(1):31-47.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use